Blog
Cyclic Peptides and Macrocycles: Why Chemists Tie Peptides Into Rings
Linear peptides are floppy. They wriggle through thousands of shapes, only a few of which fit a receptor. Tie the ends together, or staple the middle, and the number of shapes falls dramatically. That simple idea explains why many natural hormones and designed research peptides contain rings.
Key takeaways
- Cyclization constrains a peptide into fewer shapes, which often raises affinity and selectivity.
- Rings protect against exopeptidases because there are no free ends.
- Common ring types include disulfide, lactam, head-to-tail and hydrocarbon-stapled.
- The costs are harder synthesis, lower yields and trickier analysis.
The entropy argument
When a floppy peptide binds a receptor, it must freeze into one shape, which costs entropy and weakens binding. A peptide that already prefers the binding shape pays less. This preorganization is the main reason cyclic analogs are often more potent than their linear cousins, and it can also sharpen selectivity between receptor subtypes, as in the melanocortin family.
Ways to close the ring
- Disulfide bridge. Two cysteines oxidize to form an S-S bond. Oxytocin is a natural example (see cysteine and disulfide bonds). Disulfides can be reduced in cells, so they are less stable in some settings.
- Lactam bridge. An amide bond is formed between the side chain of an acidic residue such as aspartate and a basic residue such as lysine. The bond loses water on formation and is chemically very stable. Melanotan-2 uses a lactam.
- Head-to-tail cyclization. The N-terminus is joined to the C-terminus, removing both free ends. Cyclosporine, an 11-residue natural peptide with N-methylated residues, is a famous example.
- Stapling. Two olefin-bearing residues are joined by a hydrocarbon bridge, typically to hold a helix in place.
- Thioether and click-chemistry rings. Used when a disulfide would be too fragile.
Rings and enzymes
Proteases usually need a flexible, extended chain to fit their active site. A rigid ring is a poor substrate, and without free ends there is nothing for exopeptidases to start from. Rings often extend half-life compared with linear forms, which complements the tricks in our post on engineering peptide half-life.
The difficulties
- Dimerization. Closing a ring competes with linking two chains together, so cyclization is done at high dilution.
- Yield. Ring closure may be incomplete.
- Isomers. With several cysteines, disulfides can pair up in the wrong way, giving scrambled isomers with the same mass.
- Analysis. A successful lactam has a mass 18.011 lower than the open chain, and a disulfide 2.016 lower, so mass confirms closure, but not which bonds formed.
The bottom line
Rings turn a floppy chain into a shaped tool. When you meet a cyclic research peptide, ask which type of bridge it has, since that decides how stable it is under reducing conditions and how it is analyzed.
Related reading
- Cysteine and Disulfide Bonds: A Handling Guide for Peptide Researchers
- Melanocortin Receptors MC1R to MC5R: A Map for Reading Melanotan Research
- How Researchers Make Peptides Last Longer: D-Amino Acids, Acylation and More
- Browse the full Research Library
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.